Science

(Reuters) – Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo Two doses of Stelara, already approved for psoriasis, psoriatic
0 Comments
(Reuters) – Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals , which targets a rare genetic disease was approved by the U.S. Food and Drug Administration. Akcea’s once-weekly injection, Tegsedi, treats hereditary ATTR amyloidosis patients with polyneuropathy. Polyneuropathy, a symptom of the disease, is the simultaneous malfunction of peripheral nerves
0 Comments
SEATTLE (Reuters) – Jeff Bezos’ space company is in the conceptual design phase of a large lunar lander that it says will provide reusable access to the moon’s surface and its resources, Blue Origin said on Wednesday. FILE PHOTO: Amazon and Blue Origin founder Jeff Bezos addresses the media about the New Shepard rocket booster
0 Comments